1. COVID-19 vaccine AE reports in Australia and New Zealand

   News item 20 March 2021 Pages: 1 - 1

2. EMA assessing cases of blood clots after AstraZeneca COVID-19 vaccine

   News item 20 March 2021 Pages: 2 - 2

3. Health Canada finds no link between cefuroxime and Kounis syndrome

   News item 20 March 2021 Pages: 3 - 3

4. Reports of flu-like symptoms after COVID-19 vaccination

   News item 20 March 2021 Pages: 4 - 4

5. Vildagliptin and ACE inhibitors: risk of angioedema

   News item 20 March 2021 Pages: 5 - 5

6. COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis

   Clinical study 20 March 2021 Pages: 6 - 6

7. Fetal exposure to common acne treatments in the USA

   Clinical study 20 March 2021 Pages: 7 - 7

8. Influenza virus RIV4 vaccine (Flublok Quadrivalent): VAERS reports

   Clinical study 20 March 2021 Pages: 8 - 8

9. Systematic review: adverse events with antipsychotics

   Clinical study 20 March 2021 Pages: 9 - 9

10. Systematic review: S1P modulators in immune-mediated diseases

    Clinical study 20 March 2021 Pages: 10 - 10

11. Treatment-related severe oral mucositis increases cancer costs

    Clinical study 20 March 2021 Pages: 11 - 11

12. Other adverse reaction research

    News item 20 March 2021 Pages: 12 - 12

13. Abacavir/dolutegravir/lamivudine

    Case report 20 March 2021 Pages: 13 - 13

14. Abacavir/lamivudine

    Case report 20 March 2021 Pages: 14 - 14

15. Abatacept

    Case report 20 March 2021 Pages: 15 - 15

16. Abatacept/rituximab/tetracosactide

    Case report 20 March 2021 Pages: 16 - 16

17. Acalabrutinib

    Case report 20 March 2021 Pages: 17 - 17

18. Acetazolamide

    Case report 20 March 2021 Pages: 18 - 18

19. Acetazolamide/aspirin interaction

    Case report 20 March 2021 Pages: 19 - 19

20. Acetylcysteine/paracetamol overdose

    Case report 20 March 2021 Pages: 20 - 20

21. Adalimumab

    Case report 20 March 2021 Pages: 21 - 21

22. Adalimumab/infliximab/purines

    Case report 20 March 2021 Pages: 22 - 22

23. Adalimumab/infliximab/ustekinumab

    Case report 20 March 2021 Pages: 23 - 23

24. Adalimumab/secukinumab

    Case report 20 March 2021 Pages: 24 - 24

25. Adalimumab/secukinumab

    Case report 20 March 2021 Pages: 25 - 25

26. Adenosine/isoprenaline

    Case report 20 March 2021 Pages: 26 - 26

27. Afatinib/erlotinib/gefitinib

    Case report 20 March 2021 Pages: 27 - 27

28. Albendazole

    Case report 20 March 2021 Pages: 28 - 28

29. Alectinib/steroids

    Case report 20 March 2021 Pages: 29 - 29

30. Alemtuzumab

    Case report 20 March 2021 Pages: 30 - 30

31. Alprazolam/fentanyl abuse

    Case report 20 March 2021 Pages: 31 - 31

32. Amiodarone

    Case report 20 March 2021 Pages: 32 - 32

33. Amlodipine/naproxen

    Case report 20 March 2021 Pages: 33 - 33

34. Amoxicillin

    Case report 20 March 2021 Pages: 34 - 34

35. Amphotericin B liposomal

    Case report 20 March 2021 Pages: 35 - 35

36. Ampicillin

    Case report 20 March 2021 Pages: 36 - 36

37. Anesthetic agents

    Case report 20 March 2021 Pages: 37 - 37

38. Antibacterials

    Case report 20 March 2021 Pages: 38 - 38

39. Antibacterials

    Case report 20 March 2021 Pages: 39 - 39

40. Antibacterials

    Case report 20 March 2021 Pages: 40 - 40

41. Anticoagulant/antiepileptic drug interactions

    Case report 20 March 2021 Pages: 41 - 41

42. Antiepileptic-drugs

    Case report 20 March 2021 Pages: 42 - 42

43. Antiepileptic-drugs

    Case report 20 March 2021 Pages: 43 - 43

44. Antiepileptics/bumetanide/chloral-hydrate

    Case report 20 March 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 20 March 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 20 March 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 20 March 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 20 March 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 20 March 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 20 March 2021 Pages: 50 - 50